This phenotypic conversion is effectively blocked by inhibition of the RNase domain of IRE1α, suggesting that targeted modulation of ER stress pathways in MDSCs may offer novel therapeutic strategies for cancer immunotherapy234. Here, ERN1 is linked to cancer.